About Response Biomedical
Response Biomedical is a company based in Vancouver (Canada) founded in 1992 was acquired by Shanghai Runda Medical Technology in June 2016.. Response Biomedical offers products and services including RAMP Tests, RAMP 200, and COVID-19 Antigen Test.
- Headquarter Vancouver, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Response Biomedical Corp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$3.12 M (USD), Post-IPO
Oct 10, 2013
-
Investors
Orbimed
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Shanghai Runda Medical Technology
(Jun 16, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Response Biomedical
Response Biomedical offers a comprehensive portfolio of products and services, including RAMP Tests, RAMP 200, and COVID-19 Antigen Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid quantitative tests for cardiovascular and infectious diseases
Self-calibrating system for acute care diagnostics
Rapid test for detecting COVID-19 antigens
Unlock access to complete
Funding Insights of Response Biomedical
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $3.1M
-
First Round
First Round
(28 May 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2013 | Amount | Post-IPO - Response Biomedical | Valuation |
investors |
|
| Aug, 2010 | Amount | Post-IPO - Response Biomedical | Valuation |
investors |
|
| May, 2009 | Amount | Post-IPO - Response Biomedical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Response Biomedical
Response Biomedical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed and Shanghai Runda Medical Technology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
In-vitro diagnostic products and services are supplied to laboratories.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Response Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Response Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Response Biomedical Comparisons
Competitors of Response Biomedical
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Response Biomedical
Frequently Asked Questions about Response Biomedical
When was Response Biomedical founded?
Response Biomedical was founded in 1992 and raised its 1st funding round 17 years after it was founded.
Where is Response Biomedical located?
Response Biomedical is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
What does Response Biomedical do?
Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical and environmental applications. RAMP represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The lateral flow based tests are available for diagnosis of Cardiovascular diseases and Infectious diseases.The RAMP system consists of a reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. RAMP clinical tests are commercially available for the early detection of heart attack and congestive heart failure through their commercial partners and distributors. In the non-clinical market, RAMP Tests are currently provided for the environmental detection of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Response has achieved CE Marking for its readers and clinical tests and its Quality Management System is registered to ISO 13485: 2003 and ISO 9001: 2008.
What products or services does Response Biomedical offer?
Response Biomedical offers RAMP Tests, RAMP 200, and COVID-19 Antigen Test.
Who are Response Biomedical's investors?
Response Biomedical has 2 investors. Key investors include Orbimed, and Shanghai Runda Medical Technology.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.